SL
SLMBP
SLM Corp
$74.90
-0.03%
$14.1B
No data for this timeframe.
Vol
Market Cap$14.1B
Cap SizeLarge Cap
SEC Reports6
Recent Activity
May 15, 2026
SEC
SLM Corp closed a $500M offering of 6.495% Fixed-to-Floating Rate Senior Notes due 2032, with net proceeds used to fund
8-K — Impact 4/10
May 7, 2026
SEC
SLM Corp is offering $500M of 6.495% senior notes due 2032, with proceeds used to fund a concurrent tender offer to reti
424B5 — Impact 3/10
May 6, 2026
SEC
SLM Corp announced a cash tender offer to purchase all outstanding $500 million 3.125% senior notes due 2026, funded by
8-K — Impact 3/10
Analyst Ratings
3Strong Buy
7Buy
4Hold
1Sell
0Strong Sell
Latest Reports
NEUTRAL
8-K
4/10
SLM Corp closed a $500M offering of 6.495% Fixed-to-Floating Rate Senior Notes due 2032, with net proceeds used to fund
May 15, 2026
NEUTRAL
424B5
3/10
SLM Corp is offering $500M of 6.495% senior notes due 2032, with proceeds used to fund a concurrent tender offer to reti
May 7, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
6 SEC filing reports analyzed. Sentiment: 1 bullish, 0 bearish, 0 mixed, 5 neutral. Avg impact: 3.7/10.
NEUTRAL
8-K
4/10
SLM Corp closed a $500M offering of 6.495% Fixed-to-Floating Rate Senior Notes due 2032, with net pr
May 15, 2026
NEUTRAL
424B5
3/10
SLM Corp is offering $500M of 6.495% senior notes due 2032, with proceeds used to fund a concurrent
May 7, 2026
NEUTRAL
8-K
3/10
SLM Corp announced a cash tender offer to purchase all outstanding $500 million 3.125% senior notes
May 6, 2026
NEUTRAL
8-K
2/10
SLM Corp appointed its CFO Peter Graham and COO Kerri Palmer as Co-Presidents, effective immediately
Apr 27, 2026
NEUTRAL
DEFA14A
2/10
SLM Corp filed additional definitive proxy materials for its 2026 annual meeting. The board recommen
Apr 27, 2026
BULLISH
8-K
8/10
SLM Corp (Sallie Mae) reported strong Q1 2026 earnings with GAAP diluted EPS of $1.54, a 10% beat ve
Apr 23, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 67% buy across 15 analysts — 3 strong buy, 7 buy, 4 hold, 1 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.4B | -6.3% | — |
| Next Q 2026-09-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.4B | -1.7% | — |
| Current FY 2026-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $1.5B | -2.8% | — |
| Next FY 2027-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $1.5B | 2.3% | — |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 3 | 7 | 4 | 1 | 0 | 67% | |
| May 1, 2026 | 3 | 7 | 4 | 1 | 0 | 67% | |
| Apr 1, 2026 | 3 | 7 | 4 | 1 | 0 | 67% | |
| Mar 1, 2026 | 3 | 7 | 3 | 1 | 1 | 67% | |
| Feb 1, 2026 | 3 | 7 | 3 | 1 | 1 | 67% | |
| Jan 1, 2026 | 3 | 7 | 4 | 0 | 1 | 67% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.